pronai therapeutics inc  product pipeline review    compare about us  contact us home research category publisher list custom research cart compare research category user guide policies contact us about us site map home  market research report  pharmaceutical  pharmaceutical companies  pharma info market research report pronai therapeutics inc  product pipeline review   published by global markets direct product code  published october   content info  pages price usd  pdf by email single user license usd  pdf by email site license usd  pdf by email global license pronai therapeutics inc  product pipeline review   published october   content info  pages description summary global markets directs pronai therapeutics inc  product pipeline review   provides an overview of the pronai therapeutics incs pharmaceutical research and development focus this report provides comprehensive information on the current therapeutic developmental pipeline of pronai therapeutics incs complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projects global markets directs report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets directs proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by global markets directs team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis the report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass products note certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease scope the report provides brief overview of pronai therapeutics inc including business description key information and facts and its locations and subsidiaries the report reviews current pipeline of pronai therapeutics incs human therapeutic division and enlists all their major and minor projects the report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones special feature on outlicensed and partnered product portfolio the report summarizes all the dormant and discontinued pipeline projects latest company statement latest news and deals relating to the pronai therapeutics incs pipeline products reasons to buy evaluate pronai therapeutics incs strategic position with total access to detailed information on its product pipeline assess the growth potential of pronai therapeutics inc in its therapy areas of focus identify new drug targets and therapeutic classes in the pronai therapeutics incs rd portfolio and develop key strategic initiatives to reinforce pipeline in those areas exploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gaps develop strategic initiatives by understanding the focus areas of pronai therapeutics inc and exploit collaboration and partnership opportunities identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage plan mergers and acquisitions effectively by identifying the most promising pipeline of pronai therapeutics inc develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope explore the dormant and discontinued projects of pronai therapeutics inc and identify potential opportunities in those areas avoid intellectual property rights related issues table of contents product code gmdhccdbtable of contents table of contents list of tables list of figures pronai therapeutics inc snapshot pronai therapeutics inc overview key information key facts pronai therapeutics inc  research and development overview key therapeutic areas pronai therapeutics inc  pipeline review pipeline products by stage of development pipeline products  monotherapy pronai therapeutics inc  pipeline products glance pronai therapeutics inc  clinical stage pipeline products phase ii productscombination treatment modalities phase i productscombination treatment modalities pronai therapeutics inc  early stage pipeline products preclinical productscombination treatment modalities discovery productscombination treatment modalities pronai therapeutics inc  drug profiles pnt product description mechanism of action rd progress pnt product description mechanism of action rd progress pnt product description mechanism of action rd progress pnt product description mechanism of action rd progress pnt product description mechanism of action rd progress pnt product description mechanism of action rd progress pnt product description mechanism of action rd progress pronai therapeutics inc  pipeline analysis pronai therapeutics inc  pipeline products by target pronai therapeutics inc  pipeline products by route of administration pronai therapeutics inc  pipeline products by molecule type pronai therapeutics inc  pipeline products by mechanism of action pronai therapeutics inc  recent pipeline updates pronai therapeutics inc  locations and subsidiaries head office other locations  subsidiaries appendix methodology coverage secondary research primary research expert panel validation contact us disclaimer list of tables pronai therapeutics inc key information pronai therapeutics inc key facts pronai therapeutics inc  pipeline by indication  pronai therapeutics inc  pipeline by stage of development  pronai therapeutics inc  monotherapy products in pipeline  pronai therapeutics inc  phase ii  pronai therapeutics inc  phase i  pronai therapeutics inc  preclinical  pronai therapeutics inc  discovery  pronai therapeutics inc  pipeline by target  pronai therapeutics inc  pipeline by route of administration  pronai therapeutics inc  pipeline by molecule type  pronai therapeutics inc  pipeline products by mechanism of action  pronai therapeutics inc  recent pipeline updates  pronai therapeutics inc other locations list of figures pronai therapeutics inc  pipeline by top  indication  pronai therapeutics inc  pipeline by stage of development  pronai therapeutics inc  monotherapy products in pipeline  pronai therapeutics inc  pipeline by top  target  pronai therapeutics inc  pipeline by top  route of administration  pronai therapeutics inc  pipeline by top  molecule type  pronai therapeutics inc  pipeline products by top  mechanism of action  phone intl  tollfreeus  europe  asia  new for   gii now purchases any market research reports from any publishers for you with noextra cost contact us for more details faq delivery time user license payment options compare multiple reports about contact user guide policies site map  copyright  global information inc all rights reserved pronai therapeutics inc  product pipeline review   infowiseguyreportscom     chat with us           us         uk login register home report categories premium reports access to  premium reports aerospace  defense agri  food automotive basic materials consumer goods  retail energy life sciences manufacturing  construction services telecom  it education security  intelligence systems technology company reports report categories aerospace  defense agri  food automotive basic materials consumer goods  retail energy life sciences manufacturing  construction services telecom  it education security  intelligence systems technology company reports publisher knowledgestore countries browse by country browse by continent browse by group  region conferences upcoming conferences seminars conferences upcoming conferences seminars countries browse by country browse by continent browse by group  region news  blog press release blog news  blogs press release blogs faqs about us about our company our team life at wgr careers contact us there are no items currently in your basket there are no items currently in your basket search home all reports pronai therapeutics inc  product pipeline review   pronai therapeutics inc  product pipeline review   wgr  october  global  pages global markets direct description table of content sample report enquiry before buy related reports pronai therapeutics inc  product pipeline review  summaryglobal markets direct’s ‘pronai therapeutics inc  product pipeline review  ’ provides an overview of the pronai therapeutics inc’s pharmaceutical research and development focusthis report provides comprehensive information on the current therapeutic developmental pipeline of pronai therapeutics inc’s complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projectsglobal markets direct’s report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets direct’s proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by global markets direct’s team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basisthe report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass productsnote certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated diseasescope the report provides brief overview of pronai therapeutics inc including business description key information and facts and its locations and subsidiaries the report reviews current pipeline of pronai therapeutics inc’s human therapeutic division and enlists all their major and minor projects the report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones  special feature on outlicensed and partnered product portfolio the report summarizes all the dormant and discontinued pipeline projects latest company statement  latest news and deals relating to the pronai therapeutics inc’s pipeline productsreasons to buy evaluate pronai therapeutics inc’s strategic position with total access to detailed information on its product pipeline assess the growth potential of pronai therapeutics inc in its therapy areas of focus identify new drug targets and therapeutic classes in the pronai therapeutics inc’s rd portfolio and develop key strategic initiatives to reinforce pipeline in those areas exploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gaps develop strategic initiatives by understanding the focus areas of pronai therapeutics inc and exploit collaboration and partnership opportunities identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage plan mergers and acquisitions effectively by identifying the most promising pipeline of pronai therapeutics inc develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope explore the dormant and discontinued projects of pronai therapeutics inc and identify potential opportunities in those areas avoid intellectual property rights related issues table of contentstable of contents list of tables list of figures pronai therapeutics inc snapshot pronai therapeutics inc overview key information key facts pronai therapeutics inc  research and development overview key therapeutic areas pronai therapeutics inc  pipeline review pipeline products by stage of development pipeline products  monotherapy pronai therapeutics inc  pipeline products glance pronai therapeutics inc  clinical stage pipeline products phase ii productscombination treatment modalities phase i productscombination treatment modalities pronai therapeutics inc  early stage pipeline products preclinical productscombination treatment modalities discovery productscombination treatment modalities pronai therapeutics inc  drug profiles pnt product description mechanism of action rd progress pnt product description mechanism of action rd progress pnt product description mechanism of action rd progress pnt product description mechanism of action rd progress pnt product description mechanism of action rd progress pnt product description mechanism of action rd progress pnt product description mechanism of action rd progress pronai therapeutics inc  pipeline analysis pronai therapeutics inc  pipeline products by target pronai therapeutics inc  pipeline products by route of administration pronai therapeutics inc  pipeline products by molecule type pronai therapeutics inc  pipeline products by mechanism of action pronai therapeutics inc  recent pipeline updates pronai therapeutics inc  locations and subsidiaries head office other locations  subsidiaries appendix methodology coverage secondary research primary research expert panel validation contact us disclaimer list of tablespronai therapeutics inc key information pronai therapeutics inc key facts pronai therapeutics inc  pipeline by indication  pronai therapeutics inc  pipeline by stage of development  pronai therapeutics inc  monotherapy products in pipeline  pronai therapeutics inc  phase ii  pronai therapeutics inc  phase i  pronai therapeutics inc  preclinical  pronai therapeutics inc  discovery  pronai therapeutics inc  pipeline by target  pronai therapeutics inc  pipeline by route of administration  pronai therapeutics inc  pipeline by molecule type  pronai therapeutics inc  pipeline products by mechanism of action  pronai therapeutics inc  recent pipeline updates  pronai therapeutics inc other locations list of figurespronai therapeutics inc  pipeline by top  indication  pronai therapeutics inc  pipeline by stage of development  pronai therapeutics inc  monotherapy products in pipeline  pronai therapeutics inc  pipeline by top  target  pronai therapeutics inc  pipeline by top  route of administration  pronai therapeutics inc  pipeline by top  molecule type  pronai therapeutics inc  pipeline products by top  mechanism of action   request a sample report name email optional request you to please fill in your corporate emailid job title company phone no your country select country afghanistan albania algeria american samoa andorra angola anguilla antigua  barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia  herzegovina botswana brazil brunei bulgaria burkina faso burundi cambodja cameroon canada cape verde cayman islands central african republic chad chile china colombia comoros congobrazzaville congokinshasa cook islands costa rica cote divoire croatia cuba cyprus czech republic denmark djibouti dominica dominican republic ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland malvinas faroes fiji finland france frenchguiana tahitifrench polinesia gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guinea guineabissau guyana haiti vatican city honduras hong kong hungary iceland india indonesia iran iraq ireland israel italy jamaica japan jordan kazakhstan kenya kiribati north korea south korea kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macao macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mexico micronesia moldova monaco mongolia montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles new caledonia new zealand nicaragua niger nigeria norfolk northern mariana norway oman pakistan palau panama papua new guinea paraguay peru philippines pitcairn poland portugal puerto rico qatar reunion romania russian federation rwanda saint helena saint lucia saint pierre and miquelon st vincent  the grenadines samoa san marino sao tome  principe saudi arabia senegal seychelles sierra leone singapore slovakia slovenia solomon islands somalia south africa spain sri lanka sudan suriname svalbard and jan mayen swaziland sweden switzerland syria taiwan tajikistan tanzania thailand togo tokelau tonga trinidad  tobago tunisia turkey turkmenistan turks and caicos islands tuvalu uganda ukraine united arab emirates united kingdom united states of america uruguay uzbekistan vanuatu venezuela viet nam virgin islands british virgin islands us wales western sahara yemen zambia zimbabwe timorleste curacao st kitts  nevis sint maarten guernsey isle of man jersey niue montenegro do you have any specific field of interest confirm make an enquiry before buying this report name email optional request you to please fill in your corporate emailid job title company phone no your country select country afghanistan albania algeria american samoa andorra angola anguilla antigua  barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia  herzegovina botswana brazil brunei bulgaria burkina faso burundi cambodja cameroon canada cape verde cayman islands central african republic chad chile china colombia comoros congobrazzaville congokinshasa cook islands costa rica cote divoire croatia cuba cyprus czech republic denmark djibouti dominica dominican republic ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland malvinas faroes fiji finland france frenchguiana tahitifrench polinesia gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guinea guineabissau guyana haiti vatican city honduras hong kong hungary iceland india indonesia iran iraq ireland israel italy jamaica japan jordan kazakhstan kenya kiribati north korea south korea kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macao macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mexico micronesia moldova monaco mongolia montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles new caledonia new zealand nicaragua niger nigeria norfolk northern mariana norway oman pakistan palau panama papua new guinea paraguay peru philippines pitcairn poland portugal puerto rico qatar reunion romania russian federation rwanda saint helena saint lucia saint pierre and miquelon st vincent  the grenadines samoa san marino sao tome  principe saudi arabia senegal seychelles sierra leone singapore slovakia slovenia solomon islands somalia south africa spain sri lanka sudan suriname svalbard and jan mayen swaziland sweden switzerland syria taiwan tajikistan tanzania thailand togo tokelau tonga trinidad  tobago tunisia turkey turkmenistan turks and caicos islands tuvalu uganda ukraine united arab emirates united kingdom united states of america uruguay uzbekistan vanuatu venezuela viet nam virgin islands british virgin islands us wales western sahara yemen zambia zimbabwe timorleste curacao st kitts  nevis sint maarten guernsey isle of man jersey niue montenegro your enquiry confirm purchase this market research report usd gbp euro yen inr user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  add to cart buy now   email report   sample report   save page   any questions   download information   check discount   download order form   email report   sample report   save page   any questions   download information   check discount   download order form contact us akash anand domain head business development saleswiseguyreportscom     us     uk rishabh arora domain head business development saleswiseguyreportscom  abu koshy domain head business development saleswiseguyreportscom     related reports × tell a friend about this report your name your email friends name friends email your enquiry send pronai therapeutics inc  plymouth township mi usa startup start up confidently with gust launch all the legal accounting and financial tools you need to start and run your company overview executive summary financials documents pronai therapeutics inc pronai is dedicated to commercializing a new class of therapies that target dna to treat patients with cancer stage product in development industry biotechnology location plymouth township mi usa currency usd founded december  employees  website pronaicom company summary pronai therapeutics is applying proprietary nucleic acidbased dna interference technology dnai® to develop novel therapeutic approaches for proliferative diseases the company was founded in  by pharmaceutical scientists who have substantial experience in the area of nucleic acid research the founders leveraged their experience to design a new class of therapies pronai’s most advanced product pnt is currently in clinical trials team richard messmann md chief medical officer dr messmann has extensive clinical and commercial experience as a medical oncologist and drugdevelopment physician he had fellowship training at the national cancer institute nci prior to becoming deputy associate director of the nci developmental therapeutics program he has also served as vp of medical affairs for endocyte director of cancer research for the great lakes cancer institute at michigan state university mina sooch mba president and ceo ms sooch brings with her over twenty years of pharmaceutical and healthcare experiences as an entrepreneur and operator strategy  finance advisor and venture capitalist prior to venture capital mina spent eight years as a global account manager at monitor group a top tier global strategy consulting firm based in boston with her client base consisting of midcap and largecap healthcare companies and multibillion dollar private equity com wendi rodrigueza phd vp of product development dr rodrigueza whose therapeutic research expertise includes cardiovascular disease oncology diabetes and metabolic diseases joins pronai after most recently serving at novartis institute of biomedical research inc nibri as director product management cardiovascular disease area prior to nibri dr rodrigueza held numerous senior research positions at both curagen and esperion therapeutics michael woolliscroft advisors joscelyn boucher honigman miller schwartz and cohn llp lawyer unconfirmed doug burlingham accountant unconfirmed previous investors apjohn ventures unconfirmed grand angels unconfirmed biosciences research commercialization center unconfirmed loading pronai therapeutics inc  product pipeline review    reportsnreports market research report welcome guest    registerlogin   contact us   about us      advanced search home ›  pharmaceuticals ›  report detail pronai therapeutics inc  product pipeline review   published october  no of pages  price  single user license us   corporate user license us     report description table of contents inquire before buying global markets directs pronai therapeutics inc product pipeline review  provides an overview of the pronai therapeutics incs pharmaceutical research and development focusthis report provides comprehensive information on the current therapeutic developmental pipeline of pronai therapeutics incs complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projectsglobal markets directs report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets directs proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by global markets directs team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basisthe report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass productsnote certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated diseasescopethe report provides brief overview of pronai therapeutics inc including business description key information and facts and its locations and subsidiariesthe report reviews current pipeline of pronai therapeutics incs human therapeutic division and enlists all their major and minor projectsthe report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestonesspecial feature on outlicensed and partnered product portfoliothe report summarizes all the dormant and discontinued pipeline projectslatest company statementlatest news and deals relating to the pronai therapeutics incs pipeline productsreasons to buyevaluate pronai therapeutics incs strategic position with total access to detailed information on its product pipelineassess the growth potential of pronai therapeutics inc in its therapy areas of focusidentify new drug targets and therapeutic classes in the pronai therapeutics incs rd portfolio and develop key strategic initiatives to reinforce pipeline in those areasexploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gapsdevelop strategic initiatives by understanding the focus areas of pronai therapeutics inc and exploit collaboration and partnership opportunitiesidentify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantageplan mergers and acquisitions effectively by identifying the most promising pipeline of pronai therapeutics incdevelop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scopeexplore the dormant and discontinued projects of pronai therapeutics inc and identify potential opportunities in those areasavoid intellectual property rights related issues pronai therapeutics inc  product pipeline review   table of contentstable of contents list of tables list of figures pronai therapeutics inc snapshot pronai therapeutics inc overview key information key facts pronai therapeutics inc  research and development overview key therapeutic areas pronai therapeutics inc  pipeline review pipeline products by stage of development pipeline products  monotherapy pronai therapeutics inc  pipeline products glance pronai therapeutics inc  clinical stage pipeline products phase ii productscombination treatment modalities phase i productscombination treatment modalities pronai therapeutics inc  early stage pipeline products preclinical productscombination treatment modalities discovery productscombination treatment modalities pronai therapeutics inc  drug profiles pnt product description mechanism of action rd progress pnt product description mechanism of action rd progress pnt product description mechanism of action rd progress pnt product description mechanism of action rd progress pnt product description mechanism of action rd progress pnt product description mechanism of action rd progress pnt product description mechanism of action rd progress pronai therapeutics inc  pipeline analysis pronai therapeutics inc  pipeline products by target pronai therapeutics inc  pipeline products by route of administration pronai therapeutics inc  pipeline products by molecule type pronai therapeutics inc  pipeline products by mechanism of action pronai therapeutics inc  recent pipeline updates pronai therapeutics inc  locations and subsidiaries head office other locations  subsidiaries appendix methodology coverage secondary research primary research expert panel validation contact us disclaimer list of tablespronai therapeutics inc key information pronai therapeutics inc key facts pronai therapeutics inc  pipeline by indication  pronai therapeutics inc  pipeline by stage of development  pronai therapeutics inc  monotherapy products in pipeline  pronai therapeutics inc  phase ii  pronai therapeutics inc  phase i  pronai therapeutics inc  preclinical  pronai therapeutics inc  discovery  pronai therapeutics inc  pipeline by target  pronai therapeutics inc  pipeline by route of administration  pronai therapeutics inc  pipeline by molecule type  pronai therapeutics inc  pipeline products by mechanism of action  pronai therapeutics inc  recent pipeline updates  pronai therapeutics inc other locations list of figurespronai therapeutics inc  pipeline by top  indication  pronai therapeutics inc  pipeline by stage of development  pronai therapeutics inc  monotherapy products in pipeline  pronai therapeutics inc  pipeline by top  target  pronai therapeutics inc  pipeline by top  route of administration  pronai therapeutics inc  pipeline by top  molecule type  pronai therapeutics inc  pipeline products by top  mechanism of action   published by global markets direct product code global markets direct did you find what you arewere looking for  if not read below and browse through other relevant pages for similar market research reports or get in touch with us through the formcontact info in your right navigation panel and well share relevant market report titles for you to explore related reports global onychomycosis tinea unguium drug detailed analysis report  this report splits onychomycosis tinea unguium drug by product drug form by product usage type this shares the history data information from  to  and forecast from  to  and this report mainly introduces volume and value marke  united states vaginal pessary market report status and outlook this report will be delivered in  business days after the order is placed the vaginal pessary market size will be xx million usd in  in united states from the xx million usd in  with a cagr compound annual growth rate xx fro  united states tuberculin market report status and outlook this report will be delivered in  business days after the order is placed the tuberculin market size will be xx million usd in  in united states from the xx million usd in  with a cagr compound annual growth rate xx from   philippines vaginal pessary market report status and outlook this report will be delivered in  business days after the order is placed the vaginal pessary market size will be xx million usd in  in philippines from the xx million usd in  with a cagr compound annual growth rate xx from   philippines tuberculin market report status and outlook this report will be delivered in  business days after the order is placed the tuberculin market size will be xx million usd in  in philippines from the xx million usd in  with a cagr compound annual growth rate xx from    malaysia vaginal pessary market report status and outlook this report will be delivered in  business days after the order is placed the vaginal pessary market size will be xx million usd in  in malaysia from the xx million usd in  with a cagr compound annual growth rate xx from   malaysia tuberculin market report status and outlook this report will be delivered in  business days after the order is placed the tuberculin market size will be xx million usd in  in malaysia from the xx million usd in  with a cagr compound annual growth rate xx from  to   japan vaginal pessary market report status and outlook this report will be delivered in  business days after the order is placed the vaginal pessary market size will be xx million usd in  in japan from the xx million usd in  with a cagr compound annual growth rate xx from  t  japan tuberculin market report status and outlook this report will be delivered in  business days after the order is placed the tuberculin market size will be xx million usd in  in japan from the xx million usd in  with a cagr compound annual growth rate xx from  to   india vaginal pessary market report status and outlook this report will be delivered in  business days after the order is placed the vaginal pessary market size will be xx million usd in  in india from the xx million usd in  with a cagr compound annual growth rate xx from  t why reportsnreportscom  market research reports and growing top fortune  organizations trust us for research data  support on call as well as emails your details are safe with us free support for your research requirements report delivery email delivery time upto  hrs  working days upto  hrs max  weekends and public holidays research support  custom research if this business study does not have the data and information analysis you need contact us with your research requirements we explore available market research reports to map your needs and share report titles with you alternatively we can also offer custom research that suits your budget and timelines share your information requirements here connect with us email salesreportsandreportscom call       home category publisher country latest reports markets discounted reports upcoming reports contact us subscription option using our subscription option you get access to market research reports and industry data of consumer goods market as per your needs get the best of consumer goods research reports by utilizing your research budgets in an optimum way more about our subscription option report alerts get email alerts about market research reports from industries and publishers of your interest please enter a valid email id thank you you have successfully subscribed to our report alerts avail upto  discount on below publisher reports technavio azoth analytics   reportsnreports all rights reserved disclamer privacy policy  terms and conditions  our market research blog  sitemap feeds rss  latest reports pronai therapeutics inc  product pipeline review    rnr market research advanced search     salesrnrmarketresearchcom search market research reports ﻿ market research assistance salesrnrmarketresearchcom on the web related markets anesthesia drugsbiosimilarbiopharmaceuticalsclinical trialdietary supplementsdietary supplementdiseases  treatmentcancer drugsdiabetes drugshypertension drugshiv related market reports home  life sciences  pharmaceuticals  therapeutics  report detail pronai therapeutics inc  product pipeline review   publisher name  global markets direct date oct no of pages  price single user license us  corporate user license us  report descriptiontable of contentnews  blogother reportsour offerings global markets directs pronai therapeutics inc product pipeline review  provides an overview of the pronai therapeutics incs pharmaceutical research and development focus this report provides comprehensive information on the current therapeutic developmental pipeline of pronai therapeutics incs complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projects global markets directs report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets directs proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by global markets directs team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis the report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass products note certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease scope the report provides brief overview of pronai therapeutics inc including business description key information and facts and its locations and subsidiaries the report reviews current pipeline of pronai therapeutics incs human therapeutic division and enlists all their major and minor projects the report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones special feature on outlicensed and partnered product portfolio the report summarizes all the dormant and discontinued pipeline projects latest company statement latest news and deals relating to the pronai therapeutics incs pipeline products reasons to buy evaluate pronai therapeutics incs strategic position with total access to detailed information on its product pipeline assess the growth potential of pronai therapeutics inc in its therapy areas of focus identify new drug targets and therapeutic classes in the pronai therapeutics incs rd portfolio and develop key strategic initiatives to reinforce pipeline in those areas exploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gaps develop strategic initiatives by understanding the focus areas of pronai therapeutics inc and exploit collaboration and partnership opportunities identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage plan mergers and acquisitions effectively by identifying the most promising pipeline of pronai therapeutics inc develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope explore the dormant and discontinued projects of pronai therapeutics inc and identify potential opportunities in those areas avoid intellectual property rights related issues pronai therapeutics inc  product pipeline review   table of contents table of contents  list of tables  list of figures  pronai therapeutics inc snapshot  pronai therapeutics inc overview  key information  key facts  pronai therapeutics inc  research and development overview  key therapeutic areas  pronai therapeutics inc  pipeline review  pipeline products by stage of development  pipeline products  monotherapy  pronai therapeutics inc  pipeline products glance  pronai therapeutics inc  clinical stage pipeline products  phase ii productscombination treatment modalities  phase i productscombination treatment modalities  pronai therapeutics inc  early stage pipeline products  preclinical productscombination treatment modalities  discovery productscombination treatment modalities  pronai therapeutics inc  drug profiles  pnt  product description  mechanism of action  rd progress  pnt  product description  mechanism of action  rd progress  pnt  product description  mechanism of action  rd progress  pnt  product description  mechanism of action  rd progress  pnt  product description  mechanism of action  rd progress  pnt  product description  mechanism of action  rd progress  pnt  product description  mechanism of action  rd progress  pronai therapeutics inc  pipeline analysis  pronai therapeutics inc  pipeline products by target  pronai therapeutics inc  pipeline products by route of administration  pronai therapeutics inc  pipeline products by molecule type  pronai therapeutics inc  pipeline products by mechanism of action  pronai therapeutics inc  recent pipeline updates  pronai therapeutics inc  locations and subsidiaries  head office  other locations  subsidiaries  appendix  methodology  coverage  secondary research  primary research  expert panel validation  contact us  disclaimer  list of tables pronai therapeutics inc key information  pronai therapeutics inc key facts  pronai therapeutics inc  pipeline by indication   pronai therapeutics inc  pipeline by stage of development   pronai therapeutics inc  monotherapy products in pipeline   pronai therapeutics inc  phase ii   pronai therapeutics inc  phase i   pronai therapeutics inc  preclinical   pronai therapeutics inc  discovery   pronai therapeutics inc  pipeline by target   pronai therapeutics inc  pipeline by route of administration   pronai therapeutics inc  pipeline by molecule type   pronai therapeutics inc  pipeline products by mechanism of action   pronai therapeutics inc  recent pipeline updates   pronai therapeutics inc other locations  list of figures pronai therapeutics inc  pipeline by top  indication   pronai therapeutics inc  pipeline by stage of development   pronai therapeutics inc  monotherapy products in pipeline   pronai therapeutics inc  pipeline by top  target   pronai therapeutics inc  pipeline by top  route of administration   pronai therapeutics inc  pipeline by top  molecule type   pronai therapeutics inc  pipeline products by top  mechanism of action   highspeed data transmission and high volume needs propel fiber optic connectors market fiber optic connectors are a substantial fragment of the global telecommunication industry optical fibers are joined using fiber optic connectors which allow the light conduction between two consecutive optical fibers an additional im…extensive use of digital technologies for diagnostic applications to boost global optical imaging market the global optical imaging system market is predicted to reach us  billion by  it is expected to grow at a stable rate and will post a cagr of more than  in the coming years the growing market infiltration of digital …foremost trends in global pet care market the global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments it is estimated that the global pet care market will grow at a cagr o…china to review its food security laws china has arisen as the globe’s firmest developing economy in addition china brags about the biggest population pool in the world in recent times the one child policy in the republic was terminated this is anticipated to upsur…improving standards of living to boost global consumer durables market consumer durables is a cataloguing of consumer goods that are not essential to be bought very often as they are fashioned in a way so as to last for an extended period of time profits in the consumer durables sector were most profoundly… global clostridium difficile treatment market research report  published jul        price us  onwards        pages  in this report the global clostridium difficile treatment market is valued at usd xx million in  and is expected to reach usd xx million by the end of  growing at a cagr of xx between  and  geographically this report is segmented into several key regions with production consumption revenue million usd market share and growth rate of clostridium difficile treatment in these regions from  to  forecast covering  north america  eu global liver disease treatment market  published jul        price us  onwards        pages  liver is the largest organ of the body and can completely recover from damage however continuous strain on the liver when treatment is delayed for a prolonged period of time can lead to severe damage to the liver and can even be fatal viral hepatitis is one of the major liver diseases affecting a large number of people across the globe this is caused by viral infections and spread through contaminated food and water poor sanitation facilities in developing countries such as ind asiapacific varicose vein treatment market report  published jul        price us  onwards        pages  in this report the asiapacific varicose vein treatment market is valued at usd xx million in  and is expected to reach usd xx million by the end of  growing at a cagr of xx between  and  geographically this report split asiapacific into several key regions with sales k units  revenue million usd  market share and growth rate of varicose vein treatment for these regions from  to  forecast  including  china  japan  so secondary hyperparathyroidism  pipeline review h  published jul        price us  onwards        pages  secondary hyperparathyroidism  pipeline review h  summary global markets directs latest pharmaceutical and healthcare disease pipeline guide secondary hyperparathyroidism  pipeline review h  provides an overview of the secondary hyperparathyroidism hormonal disorders pipeline landscape secondary hyperparathyroidism is occurs when the parathyroid glands in neck produce too much parathyroid hormone pth because calcium levels are too l elephantiasis lymphatic filariasis  pipeline review h  published jul        price us  onwards        pages  elephantiasis lymphatic filariasis  pipeline review h  summary global markets directs latest pharmaceutical and healthcare disease pipeline guide elephantiasis lymphatic filariasis  pipeline review h  provides an overview of the elephantiasis lymphatic filariasis infectious disease pipeline landscape elephantiasis commonly known as lymphatic filariasis occurs when filarial parasites are transmitted to humans through mosquitoes  hospital acquired pneumonia hap  pipeline review h  published jul        price us  onwards        pages  hospital acquired pneumonia hap  pipeline review h  summary global markets directs latest pharmaceutical and healthcare disease pipeline guide hospital acquired pneumonia hap  pipeline review h  provides an overview of the hospital acquired pneumonia hap infectious disease pipeline landscape hospital acquired pneumonia hap is defined as pneumonia acquired during hospital stay symptoms include cough fever shaking chills con amyloidosis  pipeline review h  published jul        price us  onwards        pages  amyloidosis  pipeline review h  summary global markets directs latest pharmaceutical and healthcare disease pipeline guide amyloidosis  pipeline review h  provides an overview of the amyloidosis metabolic disorders pipeline landscape abnormal accumulation of amyloid protein in the tissues results in a group of diseases known as amyloidosis it may affect the shape and functioning of the organ eventually leading to organ failure predi phenylketonuria pku  pipeline review h  published jul        price us  onwards        pages  phenylketonuria pku  pipeline review h  summary global markets directs latest pharmaceutical and healthcare disease pipeline guide phenylketonuria pku  pipeline review h  provides an overview of the phenylketonuria pku metabolic disorders pipeline landscape phenylketonuria also called pku is a rare inherited disorder that causes an amino acid called phenylalanine to build up in body symptoms include intellectual disability  sarcopenia  pipeline review h  published jul        price us  onwards        pages  sarcopenia  pipeline review h  summary global markets directs latest pharmaceutical and healthcare disease pipeline guide sarcopenia  pipeline review h  provides an overview of the sarcopenia musculoskeletal disorders pipeline landscape sarcopenia is defined as the loss of mass and muscular function with age symptoms include obesity difficulty walking or moving about lack of strength and respiratory problems treatment includes med services value for money we believe in optimum utilization of available budget and resources while servicing our clients your market research requirements we keep the same approach in focus to help you get the best value for your s ever growing inventory ranging from the smallest feasible  required data datasheets data facts swot analysis company profiles etc to full research reports that help you make decisions our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than  niche sectors one stop solution need a custom research report on medical devices market require all available business intelligence on d printing industry exploring fb sector of a particular countryregion rnrmarketresearchcom is your onestopsolution to all market intelligence needs we not only offer custom research and consulting services we also bundle reports to meet your needs and help you fetch the data analysis you require for your business dedicated client engagement not limited to only finding relevant reports for you our client engagement team dedicates its efforts to understand your business need and accordingly maps available research data to help you move forward call your client engagement executive any time of your day and get your questions answered in order to make the correct business decision saving time and efforts simply share your research requirement details with us and let us do all the hard work to find required intelligence for you when you add up our one stop solution and dedicated client engagement services mentioned above you obviously know the time and effort saving you do by working with us payment flexibility working with fortune  organizations we understand the importance of being flexible for payments share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done postpurchase research support have questions after reading a report  datasheet bought through us not sure about the methodology used for data available in the research talk to us  share your questions with us and if required we will connect you with the analystsauthors of the reports and ensure you get satisfactory answers for the same need more data  analysis  reports on the topic of your researchproject the rnrmarketresearchcom team is here for you x to support you with your postpurchase requirements subscription offers  packages get in touch with us for more details  salesrnrmarketresearchcom       ad hoc pay  as  you  go  bucket subscriptions fixed cost for of reports customize  personalize as per your needs avail upto  discount on below publisher reports azoth analytics technavio therapeutics market research reports under pharmaceuticals at rnr market research advanced search     salesrnrmarketresearchcom search market research reports market research assistance salesrnrmarketresearchcomon the web refine resultby datelast monthlast  monthslast  monthslast yearlast  years by price  home     life sciences    pharmaceuticals    therapeutics therapeutics market research reports there has been a great revolution that has been experienced in the field of medical science to make healthy living possible the contribution of the so much research in the field of therapeutics is noteworthy in this regard by definition therapeutics is the field of medical science that deals with the various therapies that can help to cure the disease and pain in fact there are different therapies that exist and can provide the treatment in a nonsurgical manner fighting with the worst of the diseases is only possible with the help of the so much innovation in the field of therapeutics some of the common therapies that are popular among the people today include the acupressure homeopathy allopathy naturopathy and many more the different therapies not only allow overcoming the different diseases but also make it possible to prevent a wide range of diseases to occur there is preventive medicine available today that can help to prevent a lot of diseases to occur to the humaview more there has been a great revolution that has been experienced in the field of medical science to make healthy living possible the contribution of the so much research in the field of therapeutics is noteworthy in this regard by definition therapeutics is the field of medical science that deals with the various therapies that can help to cure the disease and pain in fact there are different therapies that exist and can provide the treatment in a nonsurgical manner fighting with the worst of the diseases is only possible with the help of the so much innovation in the field of therapeutics some of the common therapies that are popular among the people today include the acupressure homeopathy allopathy naturopathy and many more the different therapies not only allow overcoming the different diseases but also make it possible to prevent a wide range of diseases to occur there is preventive medicine available today that can help to prevent a lot of diseases to occur to the human beings the use of vaccines and the antibodies is one such example that fall under the scope of preventive medicine indeed living a healthy life is very much possible today with the so much innovation in therapeuticsview less cancer therapeuticsinfectious diseases therapeuticsophthalmology therapeuticsdermatology therapeuticsneurology therapeuticsgastrointestinal therapeuticshematology therapeuticscardiovascular therapeuticswomens health therapeuticskidneyrespiratory therapeuticsdiabetes therapeuticsarthritis therapeuticsdental therapeuticspulmonary therapeuticsurology therapeuticsmens health therapeuticscentral nervous system cns therapeuticsallergy therapeuticsorthopedic therapeuticsent therapeuticssexually transmitted diseases therapeuticsmetabolic therapeutics therapeuticsoral therapeuticshivaids therapeuticsradiology therapeutics therapeutics market research reports titlepublishedprice global onychomycosis tinea unguium drug detailed analysis report by qyresearch group oduct type by consumers and also their price change details as a detailed analysis report it covers all details inside analysis and opinion in onychomycosis tinea unguium drug industry this report focus global market it covers djul global cephalosporin drugs market research report by qyresearch group nsumption revenue million usd market share and growth rate of cephalosporin drugs in these regions from  to  forecast covering  north america  europe  china  japan  southeast asia  indiajul global clostridium difficile treatment market research report by qyresearch group oduction consumption revenue million usd market share and growth rate of clostridium difficile treatment in these regions from  to  forecast covering  north america  europe  china  japan  southjul global pressure ulcer treatment products sales market report by qyresearch group sales k units revenue million usd market share and growth rate of pressure ulcer treatment products for these regions from  to  forecast covering  united states  china  europe  japan  southeasjul united states glycated albumin market report by qyresearch group   the west  southwest  the middle atlantic  new england  the south  the midwest with sales volume revenue value market share and growth rate of glycated albumin in these regions from  to jul global intravenous immunoglobulin ivig sales market report by qyresearch group sales k pcs revenue million usd market share and growth rate of intravenous immunoglobulin ivig for these regions from  to  forecast covering  united states  china  europe  japan  southeast jul global liver disease treatment market by technavio es affecting a large number of people across the globe this is caused by viral infections and spread through contaminated food and water poor sanitation facilities in developing countries such as india and china has led to a higher prevalence of thjul asiapacific varicose vein treatment market report by qyresearch group h sales k units  revenue million usd  market share and growth rate of varicose vein treatment for these regions from  to  forecast  including  china  japan  south korea  taiwan  india jul asiapacific titanium dental implants market report by qyresearch group th sales k units  revenue million usd  market share and growth rate of titanium dental implants for these regions from  to  forecast  including  china  japan  south korea  taiwan  india jul united states artificial tears market by manufacturers states type and application forecast to by global info research e of the reportthis report focuses on the artificial tears in united states market to split the market based on manufacturers states type and applicationmarket segment by manufacturers this report coversajul                 next » avail upto  discount on below publisher reports azoth analytics technavio pronai therapeutics inc  product pipeline review   about us solutions resources ebookswhite papers slideshares videos blog contact us register log in my account logout browse research my cart menu   close   x browse about us solutions resources contact us log out register log in life sciences»biotechnology»biotechnology company reports pronai therapeutics inc  product pipeline review   lowest prices guaranteed length publisher published date sku from   pages global markets direct october  gmd lowest prices guaranteed price from  length  pages publisher global markets direct published date october  sku gmd table of contents close window table of contents pronai therapeutics inc  product pipeline review   printer format global markets direct pronai therapeutics inc snapshotpronai therapeutics inc overview key information key facts pronai therapeutics inc  research and development overview key therapeutic areas pronai therapeutics inc  pipeline review pipeline products by stage of development pipeline products  monotherapy pronai therapeutics inc  pipeline products glance pronai therapeutics inc  clinical stage pipeline products phase ii productscombination treatment modalities phase i productscombination treatment modalities pronai therapeutics inc  early stage pipeline products preclinical productscombination treatment modalities discovery productscombination treatment modalities pronai therapeutics inc  drug profiles pnt product description mechanism of action rd progress pnt product description mechanism of action rd progress pnt product description mechanism of action rd progress pnt product description mechanism of action rd progress pnt product description mechanism of action rd progress pnt product description mechanism of action rd progress pnt product description mechanism of action rd progress pronai therapeutics inc  pipeline analysis pronai therapeutics inc  pipeline products by target pronai therapeutics inc  pipeline products by route of administration pronai therapeutics inc  pipeline products by molecule type pronai therapeutics inc  pipeline products by mechanism of action pronai therapeutics inc  recent pipeline updates pronai therapeutics inc  locations and subsidiaries head office other locations  subsidiaries appendixmethodology coverage secondary research primary research expert panel validation contact us disclaimer list of tables pronai therapeutics inc key information pronai therapeutics inc key facts pronai therapeutics inc  pipeline by indication  pronai therapeutics inc  pipeline by stage of development  pronai therapeutics inc  monotherapy products in pipeline  pronai therapeutics inc  phase ii  pronai therapeutics inc  phase i  pronai therapeutics inc  preclinical  pronai therapeutics inc  discovery  pronai therapeutics inc  pipeline by target  pronai therapeutics inc  pipeline by route of administration  pronai therapeutics inc  pipeline by molecule type  pronai therapeutics inc  pipeline products by mechanism of action  pronai therapeutics inc  recent pipeline updates  pronai therapeutics inc other locations list of figurespronai therapeutics inc  pipeline by top  indication  pronai therapeutics inc  pipeline by stage of development  pronai therapeutics inc  monotherapy products in pipeline  pronai therapeutics inc  pipeline by top  target  pronai therapeutics inc  pipeline by top  route of administration  pronai therapeutics inc  pipeline by top  molecule type  pronai therapeutics inc  pipeline products by top  mechanism of action  description close window description pronai therapeutics inc  product pipeline review   printer format global markets direct pronai therapeutics inc  product pipeline review  summaryglobal markets direct’s ‘pronai therapeutics inc  product pipeline review  ’ provides an overview of the pronai therapeutics inc’s pharmaceutical research and development focusthis report provides comprehensive information on the current therapeutic developmental pipeline of pronai therapeutics inc’s complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projectsglobal markets direct’s report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets direct’s proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by global markets direct’s team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basisthe report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass productsnote certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated diseasescopethe report provides brief overview of pronai therapeutics inc including business description key information and facts and its locations and subsidiariesthe report reviews current pipeline of pronai therapeutics inc’s human therapeutic division and enlists all their major and minor projectsthe report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones special feature on outlicensed and partnered product portfoliothe report summarizes all the dormant and discontinued pipeline projectslatest company statement latest news and deals relating to the pronai therapeutics inc’s pipeline productsreasons to buyevaluate pronai therapeutics inc’s strategic position with total access to detailed information on its product pipelineassess the growth potential of pronai therapeutics inc in its therapy areas of focusidentify new drug targets and therapeutic classes in the pronai therapeutics inc’s rd portfolio and develop key strategic initiatives to reinforce pipeline in those areasexploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gapsdevelop strategic initiatives by understanding the focus areas of pronai therapeutics inc and exploit collaboration and partnership opportunitiesidentify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantageplan mergers and acquisitions effectively by identifying the most promising pipeline of pronai therapeutics incdevelop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scopeexplore the dormant and discontinued projects of pronai therapeutics inc and identify potential opportunities in those areasavoid intellectual property rights related issues countryglobalsectorpharmaceuticals search inside this report close window search inside this report online download  purchase site license  purchase global site license  purchase   research assistance us  intl  download our ebook how to succeed using market research learn how to effectively navigate the market research process to help guide your organization on the journey to success download ebook share this report other tasks printer format order by fax currency converter pronai therapeutics inc  product pipeline review      about us blog contact us faq  usd eur gbp usd ▼ usd eur gbp € eur  usd £ gbp rest of world us toll free  advanced price from €eurusd£gbp view pricing you are here home  categories  company reports select a format  €eurusd£gbp single user electronic pdf  this is a single user license allowing one specific user access to the product the report will be emailed to you the report is sent in pdf format  €eurusd£gbp site license electronic pdf  this is a site license allowing all users within a given geographical location of your organisation access to the product the report will be emailed to you the report is sent in pdf format  €eurusd£gbp enterprisewide electronic pdf  this is an enterprise license allowing all employees within your organisation access to the product the report will be emailed to you the report is sent in pdf format  add to basket order by fax need a quote  our clients have a question email us view faqs recently viewed products partner of research and marketsvaccinating  children in  why choose research and markets worlds largest selection trusted by the best customer focused safe  secure the team at research and markets are first rate their market intelligence is relevant and accurate and the customer service fast responsive and dependable i always benefit from knowledge gained from their comprehensive studies and will continue to utilize their services read more liz dickinson ceo physical enterprises inc pronai therapeutics inc  product pipeline review   id  company profile october   pages global markets direct description table of contents samples formats  of  login to access executive summary printer friendly printable pdf brochure send to a friend pronai therapeutics inc  product pipeline review  summarythis ‘pronai therapeutics inc  product pipeline review  ’ provides an overview of the pronai therapeutics inc’s pharmaceutical research and development focusthis report provides comprehensive information on the current therapeutic developmental pipeline of pronai therapeutics inc’s complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projectsthis report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from this proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by this team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basisthe report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass productsnote certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated diseasescope the report provides brief overview of pronai therapeutics inc including business description key information and facts and its locations and subsidiaries the report reviews current pipeline of pronai therapeutics inc’s human therapeutic division and enlists all their major and minor projects the report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones special feature on outlicensed and partnered product portfolio the report summarizes all the dormant and discontinued pipeline projects latest company statement latest news and deals relating to the pronai therapeutics inc’s pipeline productsreasons to buy evaluate pronai therapeutics inc’s strategic position with total access to detailed information on its product pipeline assess the growth potential of pronai therapeutics inc in its therapy areas of focus identify new drug targets and therapeutic classes in the pronai therapeutics inc’s rd portfolio and develop key strategic initiatives to reinforce pipeline in those areas exploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gaps develop strategic initiatives by understanding the focus areas of pronai therapeutics inc and exploit collaboration and partnership opportunities identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage plan mergers and acquisitions effectively by identifying the most promising pipeline of pronai therapeutics inc develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope explore the dormant and discontinued projects of pronai therapeutics inc and identify potential opportunities in those areas avoid intellectual property rights related issues show less read more note product cover images may vary from those shown  of  login to access executive summary printer friendly printable pdf brochure send to a friend list of tableslist of figurespronai therapeutics inc snapshotpronai therapeutics inc overviewkey informationkey factspronai therapeutics inc  research and development overviewkey therapeutic areaspronai therapeutics inc  pipeline reviewpipeline products by stage of developmentpipeline products  monotherapypronai therapeutics inc  pipeline products glancepronai therapeutics inc  clinical stage pipeline productsphase ii productscombination treatment modalitiesphase i productscombination treatment modalitiespronai therapeutics inc  early stage pipeline productspreclinical productscombination treatment modalitiesdiscovery productscombination treatment modalitiespronai therapeutics inc  drug profilespntproduct descriptionmechanism of actionrd progresspntproduct descriptionmechanism of actionrd progresspntproduct descriptionmechanism of actionrd progresspntproduct descriptionmechanism of actionrd progresspntproduct descriptionmechanism of actionrd progresspntproduct descriptionmechanism of actionrd progresspntproduct descriptionmechanism of actionrd progresspronai therapeutics inc  pipeline analysispronai therapeutics inc  pipeline products by targetpronai therapeutics inc  pipeline products by route of administrationpronai therapeutics inc  pipeline products by molecule typepronai therapeutics inc  pipeline products by mechanism of actionpronai therapeutics inc  recent pipeline updatespronai therapeutics inc  locations and subsidiarieshead officeother locations  subsidiariesappendixmethodologycoveragesecondary researchprimary researchexpert panel validationcontact usdisclaimer list of tablespronai therapeutics inc key informationpronai therapeutics inc key factspronai therapeutics inc  pipeline by indication pronai therapeutics inc  pipeline by stage of development pronai therapeutics inc  monotherapy products in pipeline pronai therapeutics inc  phase ii pronai therapeutics inc  phase i pronai therapeutics inc  preclinical pronai therapeutics inc  discovery pronai therapeutics inc  pipeline by target pronai therapeutics inc  pipeline by route of administration pronai therapeutics inc  pipeline by molecule type pronai therapeutics inc  pipeline products by mechanism of action pronai therapeutics inc  recent pipeline updates pronai therapeutics inc other locations list of figurespronai therapeutics inc  pipeline by top  indication pronai therapeutics inc  pipeline by stage of development pronai therapeutics inc  monotherapy products in pipeline pronai therapeutics inc  pipeline by top  target pronai therapeutics inc  pipeline by top  route of administration pronai therapeutics inc  pipeline by top  molecule type pronai therapeutics inc  pipeline products by top  mechanism of action  note product cover images may vary from those shown  of  loading  of  note product cover images may vary from those shown related products marina biotech inc mrna  financial and strategic swot analysis review  swot analysis june  from €eurusd£gbp procure therapeutics limited  product pipeline review    company profile october  from €eurusd£gbp prometic life sciences inc  product pipeline review    company profile july  from €eurusd£gbp prometic life sciences inc  product pipeline review    company profile august  from €eurusd£gbp prosensa therapeutics bv  product pipeline review    company profile october  from €eurusd£gbp insys therapeutics inc  product pipeline review    company profile april  from €eurusd£gbp fate therapeutics inc  product pipeline review    company profile november  from €eurusd£gbp immunomic therapeutics inc  product pipeline review    company profile february  from €eurusd£gbp io therapeutics inc  product pipeline review    company profile november  from €eurusd£gbp sage therapeutics inc  product pipeline review    company profile august  from €eurusd£gbp close pronai therapeutics inc  product pipeline review   close ask a question required information product pronai therapeutics inc  product pipeline review   your question your contact details title mr mrs dr miss ms prof first name last name email address country please select  united states united kingdom germany canada australia  afghanistan albania algeria american samoa andorra angola anguilla antarcticacasey antarcticascott antigua and barbuda argentina armenia aruba ascension island ashmore and cartier islands atlantic east atlantic west australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia and herzegovina botswana brazil british virgin islands brunei bulgaria burkina faso burma burundi cambodia cameroon canada cape verde cayman islands central african republic chad chile china christmas island clipperton island cocos keeling islands colombia comoros congo cook islands costa rica croatia cuba curaco cyprus czech republic democratic republic of congo denmark djibouti dominica dominican republic east timor ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland islands islas malvinas faroe islands fiji islands finland france french guiana french polynesia gabon gambia gaza strip georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guinea guineabissau guyana haiti honduras hong kong hungary iceland india indonesia iran iraq ireland israel italy ivory coast ivory coast cote divoire jamaica japan jordan kazakhstan kenya kiribati kosovo kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macau macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mayotte islands mexico micronesia moldova monaco mongolia montenegro montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles new caledonia new zealand nicaragua niger nigeria niue norfolk islands north korea northern ireland northern marianas norway oman pakistan palau palestine panama papua new guinea paraguay peru philippines poland portugal puerto rico qatar reunion romania russia rwanda saint christopher nevis saint helena saint kitts and nevis saint lucia saint martin saint vincent and the grenadines samoa san marino sao tome saudi arabia scotland senegal serbia serbia and montenegro seychelles sierra leone singapore sint maarten slovakia slovenia solomon islands somalia south africa south korea spain sri lanka sudan suriname swaziland sweden switzerland syria tahiti taiwan tajikistan tanzania thailand togo trinidad and tobago tunisia turkey turkmenistan turks and caicos islands tuvalu uganda ukraine united arab emirates united kingdom united states uruguay uzbekistan vanuatu vatican city holy see venezuela vietnam virgin islands wallis and futuna west bank west indies western sahara yemen yugoslavia zaire zambia zimbabwe phone number                                                                                                                                                                                                                                    we request your telephone number so we can contact you in the event we have difficulty reaching you via email we aim to respond to all questions on the same business day close send to a friend  required information friends details full name email address message to friend your contact details full name email address close request a quote please complete the below form and click send request to obtain a pdf quotation and order form this document will be available for immediate download and will also be emailed to you  required information your address address  address  address  city postalzip code country please select  united states united kingdom germany canada australia  afghanistan albania algeria american samoa andorra angola anguilla antarcticacasey antarcticascott antigua and barbuda argentina armenia aruba ascension island ashmore and cartier islands atlantic east atlantic west australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia and herzegovina botswana brazil british virgin islands brunei bulgaria burkina faso burma burundi cambodia cameroon canada cape verde cayman islands central african republic chad chile china christmas island clipperton island cocos keeling islands colombia comoros congo cook islands costa rica croatia cuba curaco cyprus czech republic democratic republic of congo denmark djibouti dominica dominican republic east timor ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland islands islas malvinas faroe islands fiji islands finland france french guiana french polynesia gabon gambia gaza strip georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guinea guineabissau guyana haiti honduras hong kong hungary iceland india indonesia iran iraq ireland israel italy ivory coast ivory coast cote divoire jamaica japan jordan kazakhstan kenya kiribati kosovo kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macau macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mayotte islands mexico micronesia moldova monaco mongolia montenegro montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles new caledonia new zealand nicaragua niger nigeria niue norfolk islands north korea northern ireland northern marianas norway oman pakistan palau palestine panama papua new guinea paraguay peru philippines poland portugal puerto rico qatar reunion romania russia rwanda saint christopher nevis saint helena saint kitts and nevis saint lucia saint martin saint vincent and the grenadines samoa san marino sao tome saudi arabia scotland senegal serbia serbia and montenegro seychelles sierra leone singapore sint maarten slovakia slovenia solomon islands somalia south africa south korea spain sri lanka sudan suriname swaziland sweden switzerland syria tahiti taiwan tajikistan tanzania thailand togo trinidad and tobago tunisia turkey turkmenistan turks and caicos islands tuvalu uganda ukraine united arab emirates united kingdom united states uruguay uzbekistan vanuatu vatican city holy see venezuela vietnam virgin islands wallis and futuna west bank west indies western sahara yemen yugoslavia zaire zambia zimbabwe state your details title mr mrs dr miss ms prof first name last name organisation email address phone number                                                                                                                                                                                                                                    po number if applicable product format license format properties price single user electronic pdf the report will be emailed to you the report is sent in pdf format this is a single user license allowing one specific user access to the product €eurusd£gbp site license electronic pdf the report will be emailed to you the report is sent in pdf format this is a site license allowing all users within a given geographical location of your organisation access to the product €eurusd£gbp enterprisewide electronic pdf the report will be emailed to you the report is sent in pdf format this is an enterprise license allowing all employees within your organisation access to the product €eurusd£gbp  the price quoted above is only valid for  days please submit your order within that time frame to avail of this price as all prices are subject to change pronai therapeutics inc  srra  stock price today  zacks free gift for zackscom visitors srra is up  today but wheres it headed in august privacy policy no cost no obligation to buy anything ever join sign in member sign in keep me signed in what does remember me do forgot password create a new account you are being directed to zackstrade a division of lbmz securities and licensed brokerdealer zackstrade and zackscom are separate companies the web link between the two companies is not a solicitation or offer to invest in a particular security or type of security zackstrade does not endorse or adopt any particular investment strategy any analyst opinionratingreport or any approach to evaluating indiv idual securities if you wish to go to zackstrade click ok if you do not click cancel ok cancel back to top more pronai therapeutics inc srra delayed data from nsdq  usd     updated jul    pm et add to portfolio zacks rank hold          style scores c value  c growth  d momentum  c vgm the style scores are a complementary set of indicators to use alongside the zacks rank it allows the user to better focus on the stocks that are the best fit for his or her personal trading style the scores are based on the trading styles of value growth and momentum theres also a vgm score v for value g for growth and m for momentum which combines the weighted average of the individual style scores into one score value score a growth score a momentum score a vgm score a within each score stocks are graded into five groups a b c d and f as you might remember from your school days an a is better than a b a b is better than a c a c is better than a d and a d is better than an f as an investor you want to buy stocks with the highest probability of success that means you want to buy stocks with a zacks rank  or  strong buy or buy which also has a score of an a or a b in your personal trading style zacks style scores education  learn more about the zacks style scores industry rank top  out of  industry medical  drugs view all zacks  ranked stocks trades from  this is our short term rating system that serves as a timeliness indicator for stocks over the next  to  months how good is it see rankings and related performance below zacks rank definition annualized return  strong buy   buy   hold   sell   strong sell  sp   zacks rank education  learn about the zacks rank zacks rank home  zacks rank resources in one place zacks premium  the only way to fully access the zacks rank the zacks equity research reports or zer for short are our inhouse independently produced research reports the ever popular onepage snapshot reports are generated for virtually every single zacks ranked stock its packed with all of the companys key stats and salient decision making information including the zacks rank zacks industry rank style scores the price consensus  surprise chart graphical estimate analysis and how a stocks stacks up to its peers the detailed multipage analyst report does an even deeper dive on the companys vital statistics in addition to all of the proprietary analysis in the snapshot the report also visually displays the four components of the zacks rank agreement magnitude upside and surprise provides a comprehensive overview of the company business drivers complete with earnings and sales charts a recap of their last earnings report and a bulleted list of reasons to buy or sell the stock it also includes an industry comparison table to see how your stock compares to its expanded industry and the sp  researching stocks has never been so easy or insightful as with the zer analyst and snapshot reports learn more about zacks equity research reports see more zacks equity research reports the zacks industry rank assigns a rating to each of the  x expanded industries based on their average zacks rank an industry with a larger percentage of zacks rank s and s will have a better average zacks rank than one with a larger percentage of zacks rank s and s the industry with the best average zacks rank would be considered the top industry  out of  which would place it in the top  of zacks ranked industries the industry with the worst average zacks rank  out of  would place in the bottom  zacks rank education  learn more about the zacks rank zacks industry rank education  learn more about the zacks industry rank quote overview stock activity open  day low  day high   wk low   wk high  avg volume  market cap  m dividend    beta  key earnings data earnings esp  most accurate est  current qtr est  current yr est  exp earnings date  prior year eps  exp eps growth yrna forward pe na peg ratio na medical » medical  drugs zacks earnings esp expected surprise prediction looks to find earnings surprises by focusing on the most recent analyst revisions this is done because generally speaking if an analyst reevaluates their earnings estimate right before an earnings release it means that they have fresh information which could potentially be more accurate than what analysts thought about a company two or three months ago the crux of this approach is comparing the most accurate estimate to the zacks consensus estimate although the zacks rank is also an important feature of the esp metric combining these two can help investors find stocks that are ready to beat the consensus at their next report and hopefully surge higher in price too in fact when combining a zacks rank  or better and a positive earnings esp stocks produced a positive surprise  of the time and best of all by using these parameters investors have seen  annual returns on average according to our  year backtest visit the earnings esp center see the full list of stocks to beat earnings research report for srra all zacks’ analyst reports news for srra zacks news for srra other news for srra new strong buy stocks for march rd am est zacks srra what are zacks experts saying now zacks private portfolio services more zacks news for srra revisiting the pronaisierra oncology thesis  year later still not dead in the water am est seeking alpha sierra oncologys sra shows encouraging safety characteristics in earlystage stage studies shares ahead  premarket am est seeking alpha premarket gainers as of  am am est seeking alpha sareum licensee sierra oncology gets patents for sra in us europe am est alliance news sierra oncology misses by  am est seeking alpha more other news for srra premium research for srra zacks rank hold  zacks industry rank top  out of  zacks sector rank bottom   out of  style scores c value  c growth  d momentum  c vgm earnings esp  research report for srra snapshot this is our short term rating system that serves as a timeliness indicator for stocks over the next  to  months how good is it see rankings and related performance below zacks rank definition annualized return  strong buy   buy   hold   sell   strong sell  sp   zacks rank education  learn more about the zacks rank zacks rank home  all zacks rank resources in one place zacks premium  the only way to get access to the zacks rank the style scores are a complementary set of indicators to use alongside the zacks rank it allows the user to better focus on the stocks that are the best fit for his or her personal trading style the scores are based on the trading styles of value growth and momentum theres also a vgm score v for value g for growth and m for momentum which combines the weighted average of the individual style scores into one score value score a growth score a momentum score a vgm score a within each score stocks are graded into five groups a b c d and f as you might remember from your school days an a is better than a b a b is better than a c a c is better than a d and a d is better than an f as an investor you want to buy stocks with the highest probability of success that means you want to buy stocks with a zacks rank  or  strong buy or buy which also has a score of an a or a b in your personal trading style zacks style scores education  learn more about the zacks style scores the zacks industry rank assigns a rating to each of the  x expanded industries based on their average zacks rank an industry with a larger percentage of zacks rank s and s will have a better average zacks rank than one with a larger percentage of zacks rank s and s the industry with the best average zacks rank would be considered the top industry  out of  which would place it in the top  of zacks ranked industries the industry with the worst average zacks rank  out of  would place in the bottom  zacks rank education  learn more about the zacks rank zacks industry rank education  learn more about the zacks industry rank the zacks sector rank assigns a rating to each of the  sectors based on their average zacks rank a sector with a larger percentage of zacks rank s and s will have a better average zacks rank than one with a larger percentage of zacks rank s and s zacks sector rank education  learn more about the zacks sector rank the sector with the best average zacks rank would be considered the top sector  out of  which would place it in the top  of zacks ranked sectors the sector with the worst average zacks rank  out of  would place in the bottom  zacks rank education  learn more about the zacks rank zacks sector rank education  learn more about the zacks sector rank the zacks equity research reports or zer for short are our inhouse independently produced research reports the ever popular onepage snapshot reports are generated for virtually every single zacks ranked stock its packed with all of the companys key stats and salient decision making information including the zacks rank zacks industry rank style scores the price consensus  surprise chart graphical estimate analysis and how a stocks stacks up to its peers the detailed multipage analyst report does an even deeper dive on the companys vital statistics in addition to all of the proprietary analysis in the snapshot the report also visually displays the four components of the zacks rank agreement magnitude upside and surprise provides a comprehensive overview of the company business drivers complete with earnings and sales charts a recap of their last earnings report and a bulleted list of reasons to buy or sell the stock it also includes an industry comparison table to see how your stock compares to its expanded industry and the sp  researching stocks has never been so easy or insightful as with the zer analyst and snapshot reports learn more about zacks equity research reports see more zacks equity research reports zacks earnings esp expected surprise prediction looks to find earnings surprises by focusing on the most recent analyst revisions this is done because generally speaking if an analyst reevaluates their earnings estimate right before an earnings release it means that they have fresh information which could potentially be more accurate than what analysts thought about a company two or three months ago the crux of this approach is comparing the most accurate estimate to the zacks consensus estimate although the zacks rank is also an important feature of the esp metric combining these two can help investors find stocks that are ready to beat the consensus at their next report and hopefully surge higher in price too in fact when combining a zacks rank  or better and a positive earnings esp stocks produced a positive surprise  of the time and best of all by using these parameters investors have seen  annual returns on average according to our  year backtest visit the earnings esp center see the full list of stocks to beat earnings this is our short term rating system that serves as a timeliness indicator for stocks over the next  to  months how good is it see rankings and related performance below zacks rank definition annualized return  strong buy   buy   hold   sell   strong sell  sp   zacks rank education  learn more about the zacks rank zacks rank home  all zacks rank resources in one place zacks premium  the only way to fully access the zacks rank the zacks industry rank assigns a rating to each of the  x expanded industries based on their average zacks rank an industry with a larger percentage of zacks rank s and s will have a better average zacks rank than one with a larger percentage of zacks rank s and s the industry with the best average zacks rank would be considered the top industry  out of  which would place it in the top  of zacks ranked industries the industry with the worst average zacks rank  out of  would place in the bottom  zacks rank education  learn more about the zacks rank zacks industry rank education  learn more about the zacks industry rank the zacks sector rank assigns a rating to each of the  sectors based on their average zacks rank a sector with a larger percentage of zacks rank s and s will have a better average zacks rank than one with a larger percentage of zacks rank s and s zacks sector rank education  learn more about the zacks sector rank the sector with the best average zacks rank would be considered the top sector  out of  which would place it in the top  of zacks ranked sectors the sector with the worst average zacks rank  out of  would place in the bottom  zacks rank education  learn more about the zacks rank zacks sector rank education  learn more about the zacks sector rank the style scores are a complementary set of indicators to use alongside the zacks rank it allows the user to better focus on the stocks that are the best fit for his or her personal trading style the three scores are based on the trading styles of growth value and momentum growth score a value score a momentum score a within each score stocks are graded into five groups a b c d and f as you might remember from your school days an a is better than a b a b is better than a c a c is better than a d and a d is better than an f as an investor you want to buy stocks with the highest probability of success that means you want to buy stocks with a zacks rank  or  strong buy or buy which also has a score of an a or a b zacks style scores education  learn more about the zacks style scores the style scores are a complementary set of indicators to use alongside the zacks rank it allows the user to better focus on the stocks that are the best fit for his or her personal trading style the scores are based on the trading styles of value growth and momentum theres also a vgm score v for value g for growth and m for momentum which combines the weighted average of the individual style scores into one score value score a growth score a momentum score a vgm score a within each score stocks are graded into five groups a b c d and f as you might remember from your school days an a is better than a b a b is better than a c a c is better than a d and a d is better than an f as an investor you want to buy stocks with the highest probability of success that means you want to buy stocks with a zacks rank  or  strong buy or buy which also has a score of an a or a b in your personal trading style zacks style scores education  learn more about the zacks style scores the zacks equity research reports or zer for short are our inhouse independently produced research reports the ever popular onepage snapshot reports are generated for virtually every single zacks ranked stock its packed with all of the companys key stats and salient decision making information including the zacks rank zacks industry rank style scores the price consensus  surprise chart graphical estimate analysis and how a stocks stacks up to its peers the detailed multipage analyst report does an even deeper dive on the companys vital statistics in addition to all of the proprietary analysis in the snapshot the report also visually displays the four components of the zacks rank agreement magnitude upside and surprise provides a comprehensive overview of the company business drivers complete with earnings and sales charts a recap of their last earnings report and a bulleted list of reasons to buy or sell the stock it also includes an industry comparison table to see how your stock compares to its expanded industry and the sp  researching stocks has never been so easy or insightful as with the zer analyst and snapshot reports learn more about zacks equity research reports see more zacks equity research reports   change in last  days view all zacks rank  strong buys premium research industry analysis top peers symbol zacks rank pronai therapeutics inc srra aerie pharmaceuticals inc aeri chemocentryx inc ccxi consort medical plc sponsored adr csrmy ionis pharmaceuticals inc ions recordati industria chimica e farmaceutica spa rcdtf summit therapeutics plc smmt see all medical  drugs peers price and eps surprise chart  month  months ytd interactive chart  fundmental chart billion dollar secret company summary sierra oncology inc is a clinicalstage drug development company it develops and markets drugs for the treatment of cancer the product pipeline consists of sra and sra sra is an orally bioavailable small molecule inhibitor of checkpoint kinase  a key cell cycle checkpoint and central regulator of the dna damage response network sra is an orally available small molecule inhibitor of cell division cycle kinase sierra oncology inc formerly known as pronai therapeutics inc is headquatered in vancouver canada pronai therapeutics inc nasdaq  dnai  bragar eagel  squire law firm openclose menu a fullservice boutique litigation law firm pronai therapeutics inc nasdaq  dnai company name pronai therapeutics inc stock symbol dnai class period july   to june   lead plaintiff deadline january   court new york southern district court status under investigation new york november   – bragar eagel  squire pc announces that a class action lawsuit has been filed in the united states district court for the new york southern district court on behalf of all persons or entities who acquired pronai therapeutics inc nasdaq dnai securities between july   to june   the “class period” the complaint alleges that throughout the class period pronai made materially false and misleading statements about the potential and efficacy of its drug product candidate pnt in the company’s public filings which caused pronai’s stock price to be artificially inflated throughout the class period thus harming investors on june   pronai revealed that the phase  clinical trials of pnt failed to produce sufficient efficacy results to justify continued clinical development of the drug and thus pronai was suspending clinical development of pnt following this news shares of pronai fell more than  percent if you acquired pronai securities during the class period have information or would like to learn more about these claims or have any questions concerning this announcement or your rights or interests with respect to these matters please contact j brandon walker esq by email at investigationsbespccom or telephone at   or by filling out the contact form below there is no cost or obligation to you join the action by filling out the form below first name last name city state zip code email address daytime phone evening phone shares owned join action yesno additional comments the submission of this form does not create an attorneyclient relationship nor any obligation on the part of bragar eagel  squire pc or you to file a legal action any information you submit will be maintained as confidential if bragar eagel  squire pc in its sole discretion believes that you might be an appropriate class representative bragar eagel  squire pc will contact you to discuss the matter and to determine whether to establish an attorney client relationship   bragar eagel  squire pc attorney advertising – disclaimer   homeabout our firmattorneys▼raymond bragarlawrence eageljeffrey squiredavid j stonebrandon walkertodd h hendersonmelissa a fortunatoderek scherrpractice areas▼alternative dispute resolutionbankruptcy and insolvencyrelated litigationclass actions securities  derivativesgeneral commercial litigationreal estate and construction litigationcases▼representative casesnew federal securities actionsnew investigationsnewsblogcontact us pronai therapeutics inc names new president and chief executive officer  business wire pronai therapeutics inc names new president and chief executive officer september    am eastern daylight time plymouth michbusiness wirepronai therapeutics inc a developer of novel nucleic acid therapeutics announces the appointment nick glover phd as president and chief executive officer the company’s previous ceo mina sooch will be leaving the organization to pursue new opportunities dr glover an accomplished biotech executive brings to pronai therapeutics extensive experience in the field of oncology drug development dr glover most recently served as president and chief executive officer of ym biosciences inc nyse ymi tsx ym a publicly traded oncology drug development company acquired by gilead sciences inc in february  previously dr glover was president and chief executive officer of viventia biotech inc a drug development company developing novel therapies for cancer and investment manager at mds capital a life sciences venture capital firm he currently serves on the board of directors of mei pharma inc a company focused on cancer drug development nasdaq meip dr glover holds a bsc in chemistry from the university of east anglia norwich england and a phd in chemistry from simon fraser university british columbia canada on behalf of pronais board chairman donald parfet said the company’s organization has reached a critical juncture we have demonstrated an exciting therapeutic value in pnt our lead product and now need to accelerate our efforts with expanded latestage clinical trials by placing a leader with nick’s talents and demonstrated capabilities we significantly strengthen our abilities to commercialize the product line mr parfet continued nick’s strong reputation in cancer drug development and his extensive experience leading public and private biotechnology companies make him a superb choice to lead pronai at this critical time “i’ve been highly impressed by the quality of the development and clinical work conducted by the pronai team resulting in a portfolio of promising novel drug candidates i am excited and honored to join pronai and look forward in particular to further advancing the clinical development of pnt which has generated compelling results to date” stated dr glover “there is a significant need to develop and deliver therapies that will make a meaningful difference in the lives of cancer patients pronai’s proprietary dnai technology is a promising emerging modality that has the potential to yield impactful oncology therapeutics and i look forward to leading the company and bringing these novel treatments to patients” donald parfet continued on behalf of all of pronai’s stakeholders i would like to thank mina sooch for her outstanding contributions to the company pronai has made great strides under mina’s stewardship raising significant capital and successfully positioning pronai for aggressive growth and value creation mina is a talented entrepreneur and seasoned life sciences executive and we wish her every success in her future endeavors about pnt pnt comprises a base singlestranded chemicallyunmodified dna oligonucleotide pnt encapsulated in a specialized anionic and phsensitive liposome in preclinical studies the beneficial activity of pnt has been demonstrated as a single agent and in combination with cdtargeted antibody therapy and other chemotherapeutic agents in a variety of hematological and solid tumor xenograft models pnt exhibited systemic exposure and cellular uptake resulting in cell death by modulation of the bcl gene to date  patients have been treated with pnt across phase i tolcher aw et al  cancer chemotherapy and pharmacology   and pilot phase ii studies abstract oral presentation novel agents in lymphoma therapy session american society of hematology ash annual meeting december  about pronai therapeutics inc pronai therapeutics is advancing dna interference dnai® technology a proprietary and differentiated nucleic acid therapeutic modality dnai utilizes singlestranded unmodified phosphodiester dna sequences designed to specifically hybridize to genomic dna and modulate gene transcription beyond pnt the company is developing dnai assets against other cancer and noncancer targets for more information visit wwwpronaicom forwardlooking statements statements made in this press release that look forward in time or that express expectations regarding future occurrences or anticipated outcomes or benefits are forwardlooking statements a number of risks and uncertainties such as risks associated with product development and commercialization efforts results of clinical trials ultimate clinical outcomes and market acceptance of the company’s products to patients intellectual property protection and competitive product offerings could cause actual events to differ from the expectations indicated in these forwardlooking statements you should not place undue reliance on forwardlooking statements because they speak only as of the date when made and may turn out to be inaccurate we do not assume any obligation to publicly update or revise any forwardlooking statements whether as a result of new information future events or otherwise we may not actually achieve the plans projections or expectations disclosed in forwardlooking statements and actual results developments or events could differ materially from those disclosed in the forwardlooking statements contacts pronai therapeutics incnick glover phdpresident  ceongloverpronaicomorpronai therapeutics inclynn speed   assistant to dr nick gloverlspeedpronaicom contacts pronai therapeutics incnick glover phdpresident  ceongloverpronaicomorpronai therapeutics inclynn speed   assistant to dr nick gloverlspeedpronaicom search advanced news search advanced news search log in sign up microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft pronai therapeutics  health   web results aol search skip over navigation search the web web images images searches related topronai therapeutics pronai therapeutics website sierra oncology pronai therapeutics plymouth mi pronai pronai therapeutics news pronai stock pronai therapeutics latest news pronai therapeutics ipo web results pronai therapeutics raises  million series d  wwwbusinesswirecomenpronaitherapeuticsraisesmillion pronai therapeutics raises  million series d financing proceeds will advance clinical studies of its bcl targeted cancer drug and other pipelin pronai therapeutics chiasma shares rise quickly following  httpswwwwsjcomarticlespronaitherapeuticschiasmashares shares of pronai therapeutics inc and chiasma inc rose quickly following the companies’ initial public offerings thursday continuing a solid run of new offerings  pronai therapeutics  linkedin httpswwwlinkedincomcompanypronaitherapeuticsinc learn about working at pronai therapeutics join linkedin today for free see who you know at pronai therapeutics leverage your professional network and get hired pronai therapeutics inc nasdaq  dnai  bragar eagel  httpsbespccompronaitherapeutics company name pronai therapeutics inc stock symbol dnai class period july   to june   lead plaintiff deadline january   court new york s pronai therapeutics inc  srra  stock price today  zacks httpswwwzackscomstockquotesrra view pronai therapeutics inc srra investment  stock information get the latest pronai therapeutics inc srra detailed stock quotes stock data realtime ecn  pronai therapeutics  dnai  stock price  news  the  wwwfoolcomquotenasdaqpronaitherapeuticsdnai real time pronai therapeutics dnai stock price quote stock graph news  analysis pronai therapeutics inc  robbins arroyo llp httpswwwrobbinsarroyocompronaitherapeuticsincdec do you own shares of pronai therapeutics inc robbins arroyo llp is investigating claims on behalf of shareholders of pronai sierra oncology inc private company information  bloomberg wwwbloombergcomresearchstocksprivatesnapshotaspprivcapid the company was formerly known as pronai therapeutics inc and changed its name to sierra oncology inc in janua detailed description   gallas v pronai therapeutics inc et al cv  httpswwwpacermonitorcompubliccasegallasvpronai gallas v pronai therapeutics inc et al cv california northern district court filed   pacermonitor mobile federal and bankruptcy court  sierra oncology  targeted cancer treatments  home httpswwwsierraoncologycom welcome to sierra oncology formerly pronai therapeutics we are pleased to announce our new name and launch our new website thank you for visiting searches related topronai therapeutics pronai therapeutics website sierra oncology pronai therapeutics plymouth mi pronai pronai therapeutics news pronai stock pronai therapeutics latest news pronai therapeutics ipo next search the web  aol inc all rights reservedprivacy   terms of use   preferences   contact us   powered by bing™ wowcom  part of the aol search network